会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明申请
    • USE OF HTRA1 FOR EARLY DETECTION OF COLORECTAL CANCER
    • 使用HTRA1早期检测彩色癌
    • WO2017060840A1
    • 2017-04-13
    • PCT/IB2016/055979
    • 2016-10-06
    • UNIVERSITÀ DEGLI STUDI DELL'AQUILA
    • ALTOBELLI, Emma
    • G01N33/574
    • G01N33/57419G01N2333/96425
    • The invention relates to a novel test for the early diagnosis of colorectal cancer (CRC),. The test measures the expression decrease of HtrA1 protein in plasma samples. Its application implies either the use of HtrA1 alone or in combination with the immunochemical fecal occult blood test (iFOBT). The latter application is called "combined test". The new test offers the advantage of affording greater sensitivity than the most reliable available fecal occult blood test (FOBT). It may be hypothesized that the test could be used for routine population-based CRC screening, either alone or combined, before patients who are positive for fecal occult blood are referred for colonoscopy.
    • 本发明涉及一种用于结直肠癌(CRC)早期诊断的新型检测方法。 该测试测量血浆样品中HtrA1蛋白的表达降低。 其应用意味着单独使用HtrA1或与免疫化学粪便潜血试验(iFOBT)组合使用。 后一种应用被称为“组合测试”。 新测试提供了比最可靠的可靠的粪便潜血试验(FOBT)提供更大的灵敏度的优点。 可以假设,在将粪便潜血阳性的患者称为结肠镜检查之前,该检测可以单独使用或组合用于常规基于人群的CRC筛查。
    • 9. 发明申请
    • USE OF HTRA1 FOR EARLY DETECTION OF COLORECTAL CANCER
    • HTRA1用于早期检测大肠癌
    • WO2017060840A4
    • 2017-06-01
    • PCT/IB2016055979
    • 2016-10-06
    • UNIVERSITÀ DEGLI STUDI DELL'AQUILA
    • ALTOBELLI EMMA
    • G01N33/574
    • G01N33/57419G01N2333/96425
    • The invention relates to a novel test for the early diagnosis of colorectal cancer (CRC),. The test measures the expression decrease of HtrA1 protein in plasma samples. Its application implies either the use of HtrA1 alone or in combination with the immunochemical fecal occult blood test (iFOBT). The latter application is called "combined test". The new test offers the advantage of affording greater sensitivity than the most reliable available fecal occult blood test (FOBT). It may be hypothesized that the test could be used for routine population-based CRC screening, either alone or combined, before patients who are positive for fecal occult blood are referred for colonoscopy.
    • 本发明涉及用于结肠直肠癌(CRC)早期诊断的新型测试。 该测试测量血浆样品中HtrA1蛋白的表达降低。 其应用意味着要么单独使用HtrA1,要么与免疫化学粪便隐血试验(iFOBT)联合使用。 后者的应用被称为“组合测试”。 新测试提供了比最可靠的大便隐血试验(FOBT)更高的灵敏度。 可以假设该检验可用于常规基于群体的CRC筛查,无论是单独使用还是联合使用,在将粪便潜血阳性的患者转诊为结肠镜检查之前。
    • 10. 发明申请
    • SYNTHESIS OF TRIDIMENSIONAL GRAPHENE OXIDE BASED MATERIALS
    • 三甲基氧化铁基材料的合成
    • WO2017017628A1
    • 2017-02-02
    • PCT/IB2016/054502
    • 2016-07-28
    • UNIVERSITÀ DEGLI STUDI DELL'AQUILACONSIGLIO NAZIONALE DELLE RICERCHE
    • IPPOLITI, RodolfoANGELUCCI, FrancescoARDINI, MatteoOTTAVIANO, LucaPERROZZI, FrancescoSANTUCCI, SandroMORANDI, VittorioORTOLANI, LucaPALERMO, Vincenzo
    • C01B31/04
    • C01B32/194C12N9/0006C12N11/14C12Y111/01015
    • The present invention relates to a three-dimensional structure made of graphene comprising at least two layers substantially constituted by graphene oxide therebetween one intermediate layer is interposed comprising protein rings or protein tubes of nanometric size as well as a process for implementing said structure. The present invention also relates to the use as adhesive, for implementing three-dimensional structures based upon hydrophilic materials, a protein capable of forming rings or tubes of nanometric dimensions having two surfaces with annular shape above and below a plane of the ring, not necessarily identical surfaces, at least partially hydrophobic and equipped with amino acids active from a redox point of view. Moreover, the present invention further relates to the manufacturing of 3D materials based upon graphene oxide functionalized with different metal species. The mineralisation of such materials is possible thanks to the engineering of the inner cavity of ring-like proteins with peptides equipped with amino acids capable of linking fixedly several metals.
    • 本发明涉及由石墨烯制成的三维结构,其包括基本上由氧化石墨烯构成的至少两层,其间插入包含蛋白质环或纳米尺寸的蛋白质管的中间层以及用于实施所述结构的方法。 本发明还涉及作为粘合剂的用途,用于实现基于亲水材料的三维结构,能够形成具有在环的平面上方和下方具有环形形状的具有环形形状的环的纳米尺寸的管的蛋白质,不一定 相同的表面,至少部分疏水并且配备有从氧化还原角度看活性的氨基酸。 此外,本发明还涉及基于用不同金属物质官能化的氧化石墨烯的3D材料的制造。 这种材料的矿化是可能的,这是由于具有装配有能够固定地连接几种金属的氨基酸的肽的环状蛋白质的内腔的工程化。